Multiple endocrine neoplasia type 2 (MEN2) is a multiple endocrine neoplasia, a polyglandular cancer syndrome characterized by the occurrence of medullary thyroid carcinoma (MTC), pheochromocytoma (PCC), in one variant, primary hyperparathyroidism (PHPT). There are three forms: MEN2A, MEN2B, and familial medullary thyroid carcinoma (FMTC). [ Orphanet:653 ]

Synonyms: multiple endocrine neoplasia type 2 MEN2

This is just here as a test because I lose it

Term information

database cross reference
  • NCIT:C123329 (MONDO:equivalentTo)
  • MedDRA:10028191 (Orphanet:653/e)
  • ICD9:194.8 (MONDO:relatedTo)
  • UMLS:C4048306 (NCIT:C123329)
  • NORD:1467 (MONDO:NORD)
  • GARD:3830 (Orphanet:653)
  • ICD9:258.02 (MONDO:i2s)
  • SCTID:61808009 (MONDO:equivalentTo)
  • Orphanet:653 (MONDO:equivalentTo)
Subsets

gard_rare, ordo_disease, rare, nord_rare, orphanet_rare

closeMatch

http://identifiers.org/meddra/10028191

exactMatch

http://identifiers.org/snomedct/61808009

http://www.orpha.net/ORDO/Orphanet_653

http://purl.obolibrary.org/obo/NCIT_C123329

http://linkedlifedata.com/resource/umls/id/C4048306

id

MONDO:0019003

seeAlso

https://rarediseases.info.nih.gov/diseases/3830/multiple-endocrine-neoplasia-type-2